Stonegate Updates Coverage on Burcon Nutrascience Corporation BU FY25 Q2
DALLAS, TX -- November 21st, 2024 --Burcon Nutrascience Corporation BU: Stonegate Capital Partners updates their coverage on Burcon Nutrascience Corporation BU. In the second quarter of 2025, Burcon made significant strides in its strategic initiatives. The Company successfully ramped up commercial production of its canola protein isolate, marking a pivotal milestone in its go-to-market strategy. With over 80 prospective customers evaluating its protein products, Burcon has built a robust sales pipeline. Additionally, The Company sees a multi-billion-dollar total addressable market for its products, with specific opportunities in the soy protein isolate market (US$70-116M), pea protein market (US$215-392M), and canola protein market (US$68-113M), among others. We note that these developments position Burcon well for future growth, driven by expanding market opportunities and strategic advancements in product commercialization.
To view the full announcement, including downloadable images, bios, and more, click here.
Key Takeaways:
- Built a robust sales pipeline with over 80 prospective customers.
- Launched Puratein® canola protein into multi-billion-dollar egg replacement market.
- Secured a partnership with a strategic investor to acquire protein production facilities starting in 1Q25.
Click image above to view full announcement.
Contacts:
Stonegate Capital Partners
(214) 987-4121
info@stonegateinc.com
Source: Stonegate, Inc.
Distributed by: Reportable, Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
